findmyKOL
Clinical trialNCT06123130CompletedInterventional

AIMIGo 12L ECG Synthesis Software Pivotal Study for Arrythmia Detection

SponsorHeartBeam, Inc.Enrollment198Arrhythmias, CardiacAtrial FibrillationAtrial FlutterBradycardiaTachycardia
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Piedmont Heart Institute

    Atlanta, Georgia, United States

  • Atlanta Heart Specialists

    Tucker, Georgia, United States

  • the Mount Sinai Hospital

    New York, New York, United States

  • Long Island Jewish Medical Center

    Queens, New York, United States

  • Allegheny Health Network

    Pittsburgh, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
13 Mar 2024
Primary completion
20 Jun 2024
Completion
20 Jun 2024
Last update posted
5 Jul 2024
Registered enrollment
198
Registry id
NCT06123130

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.